13D/13G Filings - BML Investment Partners, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-07
11:53 am
Purchase
2023-12-31 13G Climb Bio, Inc.
CLYM
BML Investment Partners, L.P. 2,350,682
8.500%
453,068increase
(+23.88%)
Filing
History
2024-02-07
11:36 am
Sale
2023-12-31 13G Adverum Biotechnologies, Inc.
ADVM
BML Investment Partners, L.P. 485,425
2.300%
-244,593decrease
(-33.51%)
Filing
History
2024-02-07
11:14 am
Purchase
2023-12-31 13G CalciMedica, Inc.
CALC
BML Investment Partners, L.P. 220,424
2.100%
220,424increase
(New Position)
Filing
History
2024-02-07
10:50 am
Sale
2023-12-31 13G Quince Therapeutics, Inc.
QNCX
BML Investment Partners, L.P. 0
0.000%
-1,841,301decrease
(Position Closed)
Filing
History
2024-02-07
10:32 am
Purchase
2024-02-07 13G AVROBIO, Inc.
AVRO
BML Investment Partners, L.P. 366,802
9.900%
36,353increase
(+11.00%)
Filing
History
2024-02-07
09:25 am
Unchanged
2023-12-31 13G Atea Pharmaceuticals, Inc.
AVIR
BML Investment Partners, L.P. 5,602,079
6.700%
0
(Unchanged)
Filing
History
2024-02-07
09:14 am
Purchase
2023-12-31 13G Atea Pharmaceuticals, Inc.
AVIR
BML Investment Partners, L.P. 5,602,079
6.700%
1,418,434increase
(+33.90%)
Filing
History
2024-01-16
5:54 pm
Purchase
2024-01-10 13G Reneo Pharmaceuticals, Inc.
RPHM
BML Investment Partners, L.P. 169,423
5.100%
169,423increase
(New Position)
Filing
History
2024-01-16
5:24 pm
Purchase
2024-01-11 13G Aclaris Therapeutics, Inc.
ACRS
BML Investment Partners, L.P. 4,500,000
6.400%
4,500,000increase
(New Position)
Filing
History
2024-01-10
5:39 pm
Purchase
2024-01-10 13D Forte Biosciences, Inc.
FBRX
BML Investment Partners, L.P. 70,468
4.800%
1,065increase
(+1.53%)
Filing
History
2023-11-24
11:33 am
Purchase
2023-11-13 13G Rain Enhancement Technologies Holdco Inc
RAIN
BML Investment Partners, L.P. 1,815,953
6.600%
1,815,953increase
(New Position)
Filing
History
2023-10-02
11:45 am
Purchase
2023-09-25 13G Atea Pharmaceuticals, Inc.
AVIR
BML Investment Partners, L.P. 4,183,645
5.000%
4,183,645increase
(New Position)
Filing
History
2023-09-15
12:00 pm
Unchanged
2023-09-15 13D Forte Biosciences, Inc.
FBRX
BML Investment Partners, L.P. 69,403
4.780%
0
(Unchanged)
Filing
History
2023-07-24
3:23 pm
Purchase
2023-07-13 13G AVROBIO, Inc.
AVRO
BML Investment Partners, L.P. 330,450
9.000%
330,450increase
(New Position)
Filing
History
2023-07-17
11:07 am
Purchase
2023-07-06 13G Quince Therapeutics, Inc.
QNCX
BML Investment Partners, L.P. 1,841,301
5.070%
1,841,301increase
(New Position)
Filing
History
2023-06-26
4:00 pm
Unchanged
2023-06-26 13D Astrotech Corporation
ASTC
BML Investment Partners, L.P. 232,065
13.700%
0
(Unchanged)
Filing
History
2023-06-12
6:57 pm
Sale
2023-06-08 13G Satsuma Pharmaceuticals, Inc.
STSA
BML Investment Partners, L.P. 0
0.000%
-6,590,000decrease
(Position Closed)
Filing
History
2023-04-27
2:19 pm
Unchanged
2023-04-17 13G Talaris Therapeutics, Inc.
TALS
BML Investment Partners, L.P. 218,919
5.200%
0
(Unchanged)
Filing
History
2023-04-27
10:55 am
Purchase
2023-04-17 13G Talaris Therapeutics, Inc.
TALS
BML Investment Partners, L.P. 218,919
5.200%
218,919increase
(New Position)
Filing
History
2023-03-29
11:17 am
Purchase
2023-03-24 13D Forte Biosciences, Inc.
FBRX
BML Investment Partners, L.P. 69,403
8.260%
10,948increase
(+18.73%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next